Area of research
Pulmonary and Respiratory Medicine · Physiology
Research interest
Research interests include Chronic Obstructive Pulmonary Disease (COPD) Research, Respiratory Support and Mechanisms, Asthma and respiratory diseases, and Inhalation and Respiratory Drug Delivery.
Neutrophil-to-Lymphocyte Ratio as a Biomarker in Clinically Stable Chronic Obstructive Pulmonary Disease: SPIROMICS Cohort
Vessel and Airway Characteristics in One-Year Computed Tomography–Defined Rapid Emphysema Progression: SPIROMICS
Phenotypes and Trajectories of Tobacco-Exposed Persons with Preserved Spirometry: Insights from Lung Volumes
Longitudinal Follow-Up of Participants With Tobacco Exposure and Preserved Spirometry
Repeatability of Pulmonary Quantitative Computed Tomography Measurements in Chronic Obstructive Pulmonary Disease
Bronchodilators in Tobacco-Exposed Persons with Symptoms and Preserved Lung Function
Reversible Airflow Obstruction Predicts Future Chronic Obstructive Pulmonary Disease Development in the SPIROMICS Cohort: An Observational Cohort Study
Forced Expiratory Flow at 25%-75% Links COPD Physiology to Emphysema and Disease Severity in the SPIROMICS Cohort
Bronchodilator Responsiveness in Tobacco-Exposed People With or Without COPD
Ambient ozone effects on respiratory outcomes among smokers modified by neighborhood poverty: An analysis of SPIROMICS AIR
Black carbon content in airway macrophages is associated with increased severe exacerbations and worse COPD morbidity in SPIROMICS
Association Among Chronic Obstructive Pulmonary Disease Severity, Exacerbation Risk, and Anxiety and Depression Symptoms in the SPIROMICS Cohort
Airway mucin MUC5AC and MUC5B concentrations and the initiation and progression of chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort
Identification of Sputum Biomarkers Predictive of Pulmonary Exacerbations in COPD
The influence of social support on COPD outcomes mediated by depression
Comparative Impact of Depressive Symptoms and FEV1% on Chronic Obstructive Pulmonary Disease
Ratio of FEV1/Slow Vital Capacity of < 0.7 Is Associated With Clinical, Functional, and Radiologic Features of Obstructive Lung Disease in Smokers With Preserved Lung Function
Contribution of Individual and Neighborhood Factors to Racial Disparities in Respiratory Outcomes
Serum IgG Levels and Risk of COPD Hospitalization
Associations Among 25-Hydroxyvitamin D Levels, Lung Function, and Exacerbation Outcomes in COPD
Clinical Phenotypes of Atopy and Asthma in COPD
Modeling residential indoor concentrations of PM <sub>2.5</sub> , NO <sub>2</sub> , NO <sub>x</sub> , and secondhand smoke in the Subpopulations and Intermediate Outcome Measures in COPD (SPIROMICS) Air study
<p>Defining Chronic Mucus Hypersecretion Using the CAT in the SPIROMICS Cohort</p>
Association of Long-term Ambient Ozone Exposure With Respiratory Morbidity in Smokers
The Effects of Rare <i>SERPINA1</i> Variants on Lung Function and Emphysema in SPIROMICS
Radiographic lung volumes predict progression to COPD in smokers with preserved spirometry in SPIROMICS
Imaging-based clusters in former smokers of the COPD cohort associate with clinical characteristics: the SubPopulations and intermediate outcome measures in COPD study (SPIROMICS)
<p>Clinical Significance of Bronchodilator Responsiveness Evaluated by Forced Vital Capacity in COPD: SPIROMICS Cohort Analysis</p>
Serum amino acid concentrations and clinical outcomes in smokers: SPIROMICS metabolomics study
Structural and Functional Features on Quantitative Chest Computed Tomography in the Korean Asian versus the White American Healthy Non-Smokers